Patent · US Active

One component fibrin glue comprising zymogens

US10555991B2 · kind B2 · utility

0Cited by

12References

9Claims

0Family size

Assignees

Omrix Biopharmaceuticals Ltd. · IL
Ethicon, Inc. · US

Inventors

Yair Pilpel · Rehovot, IL
Ashley DeAnglis · Skillman, US
Yuri Zherdev · Rehovot, IL
Sivan Doron · Arugot, IL
Anne Gorman · Hightstown, US
Israel Nur · Afula, IL

Key dates

Filing date	Jun 21, 2017
Grant date	Feb 11, 2020
Priority date	—
Expiry date	Jun 21, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21021
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is a single component sealant formulation (e.g. in a liquid form), methods for its preparation, and use. The formulation includes fibrinogen; vitamin K-dependent clotting zymogens comprising at least Factor II (FII) and Factor X (FX).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.